Literature DB >> 28857718

Understanding systemic lupus erythematosus patients' desired outcomes and their perceptions of the risks and benefits of using corticosteroids.

X Ng1, S dosReis1, R Beardsley1, L Magder2, C D Mullins1, M Petri3.   

Abstract

Introduction The use of corticosteroids in systemic lupus erythematosus (SLE) patients requires difficult trade-offs between efficacy and risk of toxicity. This qualitative study examined SLE patients' most desired outcomes and their concerns with corticosteroid use in SLE treatment. Methods SLE patients with current/past experience with using corticosteroids were recruited from the clinics at the Johns Hopkins Lupus Center and the University of Maryland Medical Center. Five in-depth interviews ( N = 5) and four focus groups ( N = 15) were conducted during which discussions were transcribed and analyzed based on a grounded theory approach. Results We identified five major themes describing SLE patients' most desired outcomes: reduction in flares, maintenance of normal activities, minimization of treatment side effects, prevention of future organ damage, and finding a cure. Further, SLE patients reported these primary concerns with the adverse effects of corticosteroids: weight gain, organ damage (particularly bone-related damage), mood swings/irritability, sleep disturbances, and dental issues. Patients appeared to be more concerned with adverse effects that immediately affected their day-to-day lives. Conclusion Knowledge gained during this study better informs how patients view the benefits and risks of corticosteroids. This can facilitate discussions between physicians and patients as they work together to determine the appropriate use of corticosteroids.

Entities:  

Keywords:  Corticosteroids; patients'; perceptions; systemic lupus erythematosus

Mesh:

Substances:

Year:  2017        PMID: 28857718      PMCID: PMC5581720          DOI: 10.1177/0961203317726375

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  38 in total

Review 1.  Qualitative research in health care. Analysing qualitative data.

Authors:  C Pope; S Ziebland; N Mays
Journal:  BMJ       Date:  2000-01-08

2.  Lack of correlation among the 3 outcomes describing SLE: disease activity, damage and quality of life.

Authors:  D D Gladman; M B Urowitz; A Ong; J Gough; A MacKinnon
Journal:  Clin Exp Rheumatol       Date:  1996 May-Jun       Impact factor: 4.473

3.  Discordant assessment of lupus activity between patients and their physicians: the Singapore experience.

Authors:  K P Leong; E Y Y Chong; K O Kong; S P Chan; B Y H Thong; T Y Lian; H H Chng; E T Koh; C L Teh; T C Lau; W G Law; Y K Cheng; H Badsha; L C Chew; W H Yong; H S Howe
Journal:  Lupus       Date:  2009-10-30       Impact factor: 2.911

4.  Learning from discordance in patient and physician global assessments of systemic lupus erythematosus disease activity.

Authors:  C Neville; A E Clarke; L Joseph; P Belisle; D Ferland; P R Fortin
Journal:  J Rheumatol       Date:  2000-03       Impact factor: 4.666

Review 5.  Quality-of-life measurements versus disease activity in systemic lupus erythematosus.

Authors:  Adnan N Kiani; Michelle Petri
Journal:  Curr Rheumatol Rep       Date:  2010-08       Impact factor: 4.592

6.  Randomized clinical trials and longitudinal observational studies in systemic lupus erythematosus: consensus on a preliminary core set of outcome domains.

Authors:  J S Smolen; V Strand; M Cardiel; S Edworthy; D Furst; D Gladman; C Gordon; D A Isenberg; J H Klippel; M Petri; L Simon; P Tugwell; F Wolfe
Journal:  J Rheumatol       Date:  1999-02       Impact factor: 4.666

7.  Accrual of organ damage over time in patients with systemic lupus erythematosus.

Authors:  Dafna D Gladman; Murray B Urowitz; Proton Rahman; Dominique Ibañez; Lai-Shan Tam
Journal:  J Rheumatol       Date:  2003-09       Impact factor: 4.666

Review 8.  Understanding the epidemiology and progression of systemic lupus erythematosus.

Authors:  Guillermo J Pons-Estel; Graciela S Alarcón; Lacie Scofield; Leslie Reinlib; Glinda S Cooper
Journal:  Semin Arthritis Rheum       Date:  2009-01-10       Impact factor: 5.532

9.  Impaired health status and the effect of pain and fatigue on functioning in clinical trial patients with systemic lupus erythematosus.

Authors:  Michelle Petri; Ariane K Kawata; Ancilla W Fernandes; Kavita Gajria; Warren Greth; Asha Hareendran; Dominique Ethgen
Journal:  J Rheumatol       Date:  2013-10-01       Impact factor: 4.666

Review 10.  Health-related quality of life measurement in adult systemic lupus erythematosus: Lupus Quality of Life (LupusQoL), Systemic Lupus Erythematosus-Specific Quality of Life Questionnaire (SLEQOL), and Systemic Lupus Erythematosus Quality of Life Questionnaire (L-QoL).

Authors:  Jinoos Yazdany
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-11       Impact factor: 4.794

View more
  2 in total

1.  Self-reported disease severity in women with systemic lupus erythematosus.

Authors:  A Dima; S Caraiola; C Delcea; R A Ionescu; C Jurcut; C Badea
Journal:  Rheumatol Int       Date:  2018-11-10       Impact factor: 2.631

2.  Lifestyle Interventions and Weight Management in Systemic Lupus Erythematosus Patients: A Systematic Literature Review and Metanalysis.

Authors:  Karla F Goessler; Bruno Gualano; Carla B Nonino; Eloisa Bonfá; Carolina Ferreira Nicoletti
Journal:  J Lifestyle Med       Date:  2022-01-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.